ALTRINSIC GLOBAL ADVISORS LLC - CABALETTA BIO INC ownership

CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 61 filers reported holding CABALETTA BIO INC in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALTRINSIC GLOBAL ADVISORS LLC ownership history of CABALETTA BIO INC
ValueSharesWeighting
Q4 2021$531,000
-63.6%
140,000
+16.7%
0.02%
-61.4%
Q3 2021$1,459,000
+30.5%
120,000
-7.7%
0.04%
+29.4%
Q2 2021$1,118,000
-16.1%
130,000
+8.3%
0.03%
-19.0%
Q1 2021$1,332,000
+6.7%
120,000
+20.0%
0.04%0.0%
Q4 2020$1,248,000
+15.1%
100,0000.0%0.04%
-4.5%
Q3 2020$1,084,000
-2.7%
100,0000.0%0.04%
-10.2%
Q2 2020$1,114,000100,0000.05%
Other shareholders
CABALETTA BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 2,106,000$32,053,32021.20%
COMMODORE CAPITAL LP 2,525,753$38,441,9614.49%
Bain Capital Life Sciences Investors, LLC 2,000,000$30,440,0003.40%
VR Adviser, LLC 1,973,253$30,032,9113.16%
Cormorant Asset Management, LP 2,879,424$43,824,8332.56%
Velan Capital Investment Management LP 150,000$2,283,0001.84%
Redmile Group, LLC 1,774,252$27,004,1151.28%
TCG Crossover Management, LLC 486,795$7,409,0201.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,340,118$35,616,5960.78%
Integral Health Asset Management, LLC 330,000$5,022,6000.70%
View complete list of CABALETTA BIO INC shareholders